1.
Mikkael A. Sekeres, Jeffrey E. Lancet, Brent L. Wood, Laurie E. Grove, Larissa Sandalic, Eric L. Sievers, Joseph G. Jurcic. Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia. haematol [Internet]. 2012Dec.31 [cited 2024Apr.23];98(1):119-28. Available from: https://haematologica.org/article/view/6524